Table 3.
Medicare Beneficiary Population and Prevalence
| Population | Prevalence |
|---|---|
| Total CMS population (2010-2011)a | 53,765,609 |
| CMS population, FFS (2010-2011)b | 15,526,034 |
| Diagnosed abusers, FFS (2010-2011) | 204,052 |
| Diagnosed abuser prevalence (2010-2011) | 13.1 per 1,000 (1.3%) |
| Diagnosed abusers with disability (2010-2011) | 155,386 |
| Proportion of diagnosed abusers with disability | 76.2% |
| At risk for abuse population, FFS (2010-2011) | 1,822,937 |
| At risk for abuse prevalence (2010-2011) | 117.4 per 1,000 (11.7%) |
| Control with opioid use population (2010 2011)c | 7,970,354 |
| Control without opioid use population (2010-2011) | 7,528,500 |
| Total control populationd | 15,498,854 |
| Prevalence of opioid use (2010-2011) | 514.3 per 1,000 (51.4%) |
| Prevalence of nonopioid use (2010-2011) | 485.7 per 1,000 (48.6%) |
aMedicare Beneficiary Summary File.
bDid not include patients who received Parts A and B through a Medicare Advantage plan.
cIncludes diagnosed abuse and at-risk abuse.
dOpioid use population + nonopioid use population.
CMS = Centers for Medicare & Medicaid Services; FFS = fee for service.